Zentek Ltd.

NASDAQ:ZTEK

Other Precious Metals

Basic Materials
$0.49 +25.56%

+$0.10 today

Market cap
$62.30M
Beta
0.47
P/E (TTM)
-9.6
EPS (TTM)
-$0.08
52W Low $0.37High $1.34

Volume 0.93M

Average 0.15M

ZTEK Inventory

Cash effect of the change in inventory; building inventory consumes cash.

Zentek Ltd.NASDAQ: ZTEK

Inventory · Q4 FY2025 · quarter ended Mar 2026

Inventory declines year over year

Q4 FY2025 inventory of CA$8.25K fell 97.5% year over year, behind the -57.6% change in trailing-twelve-month inventory. Sequentially, it fell 94.7% from the prior quarter.

Context

  • Inventory amounted to 101.4% of revenue in FY2025, up 55.8 pp from a year earlier.
  • Inventory increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -97.5% toward the trailing-twelve-month pace of -57.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$8.25K-94.7% QoQ
Last fiscal yearMar 2026
CA$168.74K-57.5% YoY
LTMMar 2026
CA$162.67K-57.6% YoY
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-97.5%——
1 year-57.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Inventory history

CAD · from the cash flow

Latest · FY2025
168.74K CAD
Year-over-year change
-57.5%

Inventory vs competitors

How ZTEK compares with its peers on the latest reported figures

  • Peers report in different currencies, so inventory is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -57.6% is the 2nd highest of 6, against a peer median of -100.0%.
  • Inventory amounts to 97.9% of revenue for ZTEK, versus a peer median of 6.7%.
ZTEK Competitors
Inventory for ZTEK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HYPRHyperfine, Inc.LTM Mar 2026$1.91M USD-173.6%+67.8%12.4%
MBOTMicrobot Medical Inc.LTM Mar 2026$1.67M USD——1593.3%
AMWLAmerican Well CorporationLTM Mar 2026$882K USD-59.1%—0.4%
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$165.69K CAD-118.9%—0.9%
ZTEKZentek Ltd.LTM Mar 2026CA$162.67K CAD-57.6%—97.9%
BYSIBeyondSpring Inc.LTM Mar 2026$58.74K USD+5974.2%——
ALXOALX Oncology Holdings Inc.LTM Mar 2026$0 USD———
CRDLCardiol Therapeutics Inc.LTM Mar 2026CA$0 CAD———
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD-100.0%——
Peer median (excluding ZTEK) —-100.0%+67.8%6.7%

Competitors are the stored peer set for ZTEK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Net Income(12.02M)(14.41M)(8.64M)(10.04M)(9.79M)
Depreciation & Amortization614.71K539.69K453.04K600.32K527.77K
Deferred Income Tax0(808.08K)000
Stock-Based Compensation4.73M3.2M01.53M0
Change in Working Capital(1.36M)(2.4M)675.37K1.48M1.5M
Accounts Receivables(536.82K)(12.84K)201.14K(906.22K)833.64K
Inventory(665.57K)(2.18M)(51.86K)397.48K168.74K
Accounts Payables831.48K000406.52K
Other Working Capital(985.52K)(198.98K)526.09K1.98M92.57K
Other Non-Cash Items48.12K917.7K1.57M150.99K2.68M
Operating Cash Flow(7.99M)(12.96M)(5.94M)(6.28M)(5.08M)
Capital Expenditures(3.99M)(2.27M)(236.3K)(1.4K)(2.03K)
Acquisitions (Net)007.38K02.38M
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(3.27M)(33.64K)1.82M360.05K0
Investing Cash Flow(7.25M)(2.31M)1.39M358.65K1.67M
Debt Repayment(122.45K)(1.1M)(177.43K)(562.11K)1.63M
Common Stock Issued35.34M083.42K3.07M3.13M
Common Stock Repurchased00(301.82K)00
Dividends Paid00000
Other Financing Activities3.6M46K(95.42K)16.01K(172.43K)
Financing Cash Flow38.82M(1.05M)(491.25K)2.52M4.59M
Effect of Forex Changes005.31M04.08K
Net Change in Cash23.58M(16.32M)268.59K(3.4M)1.19M
Free Cash Flow(11.97M)(15.23M)(6.18M)(6.28M)(5.08M)

Zentek Ltd.

NASDAQ:ZTEK

Intrinsic Alpha fair value

Locked

Current Price

$0.49

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.